7 completed, 6 enrolling by invitation, 5 recruiting, 2 active not recruiting. 6 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 4, Enrolling by invitation 1, Recruiting 1 |
| Phase 4 | 1 | Not yet recruiting 1 |
Follow Genoss Co., Ltd.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Impact of DCB-based Versus DES-based Intervention in Patients With MVCAD GENOSS® DCB (Paclitaxel-coated PTCA balloon catheter), Contemporary Drug-Eluting Stents (DES) - Multi Vessel Coronary Artery Disease, Percutaneous Coronary Intervention | Not applicable | Recruiting | Genoss Co., Ltd. | 892 | 2026-09-28 | 2026-10-09 |
| Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome Early P2Y12 Inhibitor Monotherapy, Standard Dual Antiplatelet Therapy - Acute Coronary Syndromes, STEMI | Phase 4 | Not yet recruiting | Gyeongsang National University Hospital | 1900 | 2026-07-01 | 2026-07-06 |
| Safety and Effectiveness of GENOSS PCB in Patients With Long Femoropopliteal Lesion PTA (Percutaneous Transluminal Angioplasty), Femoropopliteal Artery Disease | Recruiting | Genoss Co., Ltd. | 300 | 2026-04-13 | 2026-09-11 | |
| Clinical Outcomes of GENOSS PCB for Femoropopliteal Artery Disease PTA (Percutaneous Transluminal Angioplasty ), Femoropopliteal Artery Disease | Enrolling by invitation | Genoss Co., Ltd. | 200 | 2025-07-01 | 2026-02-18 | |
| One-Year Results of GENOSS PCB Real-World Study in Femoropopliteal Artery Disease PTA (Percutaneous Transluminal Angioplasty), Femoropopliteal Artery Disease | Enrolling by invitation | Genoss Co., Ltd. | 300 | 2025-06-17 | 2026-09-11 | |
| The Safety and Efficacy for In-segment Late Lumen Loss of the 'Genoss® SCB' Versus 'SeQuent® Please NEO' in Patients With Coronary ISR Sirolimus Coated PTCA Balloon Catheter(Genoss® SCB), Paclitaxel Coated PTCA Balloon Catheter(SeQuent® Please NEO) - Coronary Arterial Disease (CAD) | Not applicable | Enrolling by invitation | Genoss Co., Ltd. | 94 | 2025-02-19 | 2025-09-08 |
| Safety and Efficacy of GENOSS® DCB With a Shellac Plus Vitamin E Excipient in Patients With De Novo Lesion Coronary Artery Disease(CAD) | Enrolling by invitation | Genoss Co., Ltd. | 3000 | 2024-06-27 | 2025-09-05 | |
| Safety and Effectiveness of GENOSS® DES in Patients With Multivessel Coronary Artery Disease GENOSS® DES Sirolimus Eluting Coronary Stent System - Percutaneous Coronary Intervention, Multivessel Coronary Artery Disease | Enrolling by invitation | Genoss Co., Ltd. | 1000 | 2023-11-15 | 2025-10-06 | |
| Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis Genoss® DES system, Genoss® Osfit system - Drug-eluting Stent, Coronary Artery Disease | Recruiting | Genoss Co., Ltd. | 1000 | 2023-07-07 | 2023-11-01 | |
| Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES) GENOSS® DES Sirolimus Eluting Coronary Stent System - Coronary Artery Disease, Percutaneous Coronary Intervention | Enrolling by invitation | Genoss Co., Ltd. | 1000 | 2022-07-15 | 2025-10-06 | |
| Genoss DES in Patients With a High Risk of Ischemic Events (GENTLE Registry) Genoss DES - Drug-eluting Stent, Coronary Artery Disease | Completed | Yonsei University | 200 | 2022-05-26 | 2025-11-25 | |
| Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure Coronary Artery Disease, Percutaneous Coronary Intervention | Recruiting | Genoss Co., Ltd. | 1000 | 2022-05-13 | 2025-02-21 | |
| Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions GENOSS® DCB, SeQuent® Please NEO - Coronary Artery Disease | Not applicable | Completed | Genoss Co., Ltd. | 204 | 2021-09-30 | 2024-05-17 |
| Efficacy and Safety of Short Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease Percutaneous Coronary Intervention, Dual Antiplatelet Therapy | Recruiting | Genoss Co., Ltd. | 1000 | 2021-08-18 | 2025-02-21 | |
| Compare the Safety and Effectiveness of Genoss® DCB and SeQuent® Please NEO in Chinese Patients with Coronary ISR Paclitaxel Coated PTCA Balloon Catheter(Genoss® DCB), Paclitaxel Coated PTCA Balloon Catheter(SeQuent® Please NEO) - Coronary Artery Disease | Not applicable | Completed | Genoss Co., Ltd. | 224 | 2021-01-30 | 2025-02-21 |
| Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS) GENOSS Sirolimus Eluting Coronary Stent System - Acute Coronary Syndrome, Percutaneous Coronary Intervention | Active not recruiting | Genoss Co., Ltd. | 757 | 2020-03-16 | 2026-02-11 | |
| Compare the Effectiveness and Safety of Genoss® DCB and IN.PACT Admiral® DCB in Patients With Peripheral Artery Disease Genoss® DCB, IN.PACT Admiral® DCB - Peripheral Artery Disease, De Novo Stenosis | Not applicable | Completed | Genoss Co., Ltd. | 119 | 2019-03-24 | 2024-08-23 |
| Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease Coronary Arterial Disease (CAD) | Active not recruiting | Genoss Co., Ltd. | 1118 | 2018-04-19 | 2025-09-16 | |
| Efficacy and Safety of GENOSS® DES in Patients with Coronary Artery Disease Coronary Artery Disease | Completed | Genoss Co., Ltd. | 1022 | 2017-06-24 | 2025-02-20 | |
| Genoss DES Prospective Multicenter Registry Genoss DES - Coronary Artery Disease, Myocardial Ischemia | Completed | Young Jin Youn, MD, PhD | 2000 | 2016-11-18 | 2023-01-30 |
Showing 20 of 21. Sign in to see all of them.
Coronary Artery Disease (10) · Truncus Arteriosus, Persistent (3) · Acute Coronary Syndrome (2) · Angina, Unstable (1) · Myocardial Infarction (1) · Myocardial Ischemia (1) · Non-ST Elevated Myocardial Infarction (1) · Peripheral Arterial Disease (1) · ST Elevation Myocardial Infarction (1)
South Korea (19) · China (1)
Deok-Kyu Cho, MD, PhD (1) · Eun-Seok Shin, MD, PhD (1) · In-ho Chea, MD (1) · Je Hwan Won, MD (1) · Jin-Sin Koh, MD, PhD (1) · Junghan Yoon, MD, PhD (1) · Ling Tao (1)